Back to search

Article

First Reported Advanced Pancreatic Cancer With Hyperprogression Treated With PD-1 Blockade combined with chemotherapy: A Case Report And Literature Review

2024-08-06

Abstract excerpt

<title>Abstract</title> <p>Immunotherapy has demonstrated significant potential in the treatment of cancer and is now recommended as a first-line therapy for small cell lung cancer and melanoma. However, a novel response pattern has been delineated, characterized by an abrupt acceleration of tumor growth subsequent to immunotherapy. These unforeseen adverse events are denoted as hyper progressive disease (HPD). T...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1dba6a35-125e-52fa-9fed-c7c6ffca4f56
DOI
10.21203/rs.3.rs-4673771/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
First Reported Advanced Pancreatic Cancer With Hyperprogression Treated With PD-1 Blockade combined with chemotherapy: A Case Report And Literature ReviewDOI 10.21203/rs.3.rs-4673771/v1
Severe Rashes Associated With Immunotherapy and Gene Mutations in a Patient With Metastatic Pancreatic CancerSemantic proximity
Pseudoprogression in Immunotherapy and Identification of Clinical-Biologic Predictive Factors: A Retrospective Pan-Tumor Cohort StudySemantic proximity
Immunotherapy Combined with Chemotherapy versus Chemotherapy Alone in Advanced Pancreatic Ductal Adenocarcinoma: a Real-world Retrospective Cohort StudySemantic proximity
PD-1 blockade plus capecitabine as curative-intent treatment for tumor mutational burden-high multi-metastatic pancreatic ductal adenocarcinoma: A case reportSemantic proximity
An Atypical Case of Pancreatic Cancer with Mesenchymal Differentiation in a Patient with Primary Lung Adenocarcinoma: Insights into Tumor Biology and Novel Therapeutic PathwaysSemantic proximity
Durable Response of Induction Sequential Chemotherapy Combined With Nimotuzumab and Consolidative Carbon Ion Radiotherapy With Non-V600 BRAF Mutation Locally Advanced Pancreatic CancerSemantic proximity
Metastatic Pancreatic Cancer Now in Remission: A Case Report and Literature ReviewSemantic proximity
Hyperprogressive disease in patients receiving immune checkpoint inhibitors.Semantic proximity
Exceptional Response to Olaparib and Pembrolizumab for Pancreatic Adenocarcinoma With Germline BRCA1 Mutation and High Tumor Mutation Burden: Case Report and Literature Review.Semantic proximity
Investigation on potential biomarkers of hyperprogressive disease (HPD) triggered by immune checkpoint inhibitors (ICIs).Semantic proximity
Successful Immunotherapy for Pancreatic Cancer in a Patient With TSC2 and SMAD4 Mutations: A Case Report.Semantic proximity
Exploring prognostic survival factors in patients with advanced pancreatic cancer receiving PD-1 inhibitorsSemantic proximity
Select a neighboring publication to make it the new centre.